c-LEcta celebrates its 15th anniversary and is optimistic for the future
10.12.2019 10:00:00 EET | Business Wire | Press release
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development for regulated markets such as the food and pharmaceutical industries, looks back on 15 years of successful company history. In fiscal year 2019, the products the company has developed itself in particular have contributed to this positive business development. Especially c-LEcta’s product for the production of a plant-based sweetener with a sugar-like taste and DENARASE® have performed better than expected. As a result, the company has tripled its sales over the last five years. c‑LEcta is actively investing in the expansion of its corporate structures and, particularly, in the expansion of its product pipeline in order to drive its growth forward and successfully exploit future market potential.
CEO Dr. Marc Struhalla founded the biotechnology company in Leipzig in 2004 on the basis of an offshoot of the university. After initially succeeding in optimizing the company’s own technology and gaining well-known customers from industry through contract work, a pilot plant has enabled the company to manufacture its own product batches for further scaling since 2010. Three years later, the company moved to the BioCube on the site of the old Leipzig Trade Fair, laying the foundation for an urgently needed expansion of laboratory and production capacities. Since 2015, the focus has consistently shifted away from contract work in research and development to the production and marketing of the company’s own products.
The growth figures show that the change to a product company is paying off today. In the current fiscal year 2019, c-LEcta has managed to more than double its order intake in the products segment compared to 2018. The total order intake in 2019 is thus in the double-digit million-euro range for the first time. This means that the order books are well filled for 2020. The company now sells its own products to over 90 customers from 25 countries around the world. This means the company serves more than twice as many customers as five years ago. In addition, in the area of research & development, c-LEcta works with renowned customers from the food and pharmaceutical industries in strategic partnerships to bring joint product developments to market maturity.
“We are very proud of what we have achieved here in Leipzig over the past 15 years. A good idea and a unique technology have turned into a medium-sized company that delivers its products to renowned customers all over the world,” Dr. Marc Struhalla explains.
c-LEcta continued to invest in the expansion of its workforce in fiscal year 2019 in order to continue exploiting market potential in the future and to push the company’s growth forward. “We started off with three employees back in 2004. This year, we officially welcomed our 75th employee,” explains Dr. Marc Struhalla. In 2019 alone, a total of 15 new employees were recruited in the areas of research and development, quality control, administration and business development. In addition, c-LEcta continues to invest in expanding its product pipeline: In the next two years, at least three new products will be ready for the market. “But our investments in the keen minds who work for our company are much more important. We expect to see another strong increase in the number of employees next year so that we can continue to drive innovation forward,” explains CFO Thomas Pfaadt. The Leipzig-based company therefore looks forward to the coming year with great anticipation: “We see ourselves very well prepared to continue growing in 2020 and to continue c-LEcta’s success story,” Struhalla emphasizes.
About c-LEcta
c-LEcta is a world-leading biotechnology company with a focus on enzyme engineering and application in regulated markets like the food and pharma industries. The company is based in Leipzig, Germany, and has established itself as a leading player in the realization of high-value biotech products, either in the form of in-house developments or in close cooperation with industry. The company currently employs more than 70 people.
c-LEcta delivers cost-efficient and sustainable production processes which open new markets and allow for better penetration of existing markets. The company is characterized by fast and efficient development of best-in-class biotech solutions and a rapid and successful market introduction and commercialization of the resulting products. This enables c-LEcta to leverage the unique potential of its core technologies. c-LEcta has a proven track record of more than ten successfully commercialized high-value industrial biotech products.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191209005523/en/
Contact information
cometis AG
Maximilian Franz
Phone: +49 (0) 611 - 205855 – 22
Fax: +49 (0) 611 - 205855 – 66
e-mail: franz@cometis.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global and China Gas Announce Increased Long-Term LNG Agreement18.11.2026 02:00:00 EET | Press release
Today, Venture Global, Inc. (“Venture Global”; NYSE: VG) and China Gas Holdings Limited (“China Gas”; stock code: 0384.HK), a leading natural gas operator in China, announced the execution of an increased Sales and Purchase Agreement (SPA) for the total purchase of 1.0 million tonnes per annum (MTPA) of U.S. liquefied natural gas (LNG) from Venture Global for twenty years starting in 2030. This agreement upsizes the previous SPA announced by the two parties in September 2026 for the purchase of 0.5 MTPA by another newly-agreed 0.5 MTPA. Venture Global’s total current long-term offtake with China Gas is now 3.0 MTPA under 20-year SPAs supplied across Venture Global’s portfolio. "Venture Global is pleased to continue growing our LNG partnership with China Gas, a leading natural gas operator in China, and help meet the country's growing energy needs with reliable, low-cost American LNG from across our Louisiana projects,” said Venture Global CEO Mike Sabel. "We are pleased to further expa
UPS Announces Agreement to Acquire Smartways Logistics17.11.2026 23:00:00 EET | Press release
UPS (NYSE: UPS) today announced it has entered into an agreement to acquire Smartways Logistics (Smartways), a healthcare logistics provider serving Australia and New Zealand. Once completed, the acquisition will enhance UPS Healthcare’s time-critical transportation capabilities in the region. Smartways enables healthcare customers to move critical shipments quickly and reliably, with specialized services for life sciences, medical devices, clinical trials and radiopharmaceuticals. The acquisition will build on UPS Healthcare’s ability to deliver for customers with urgent and complex logistics needs, while expanding the services available in Australia, New Zealand and the Asia Pacific region. “As healthcare becomes increasingly complex, logistics plays an even more critical role. It takes specialized capabilities and precision at every step to help vital healthcare products reach patients safely, reliably and when they’re needed,” said Wilfredo Ramos, UPS EVP and Chief International, H
Spatial Announces Release 2027 1.0 with New Enhancements Across CAD Modeling, Interoperability, Data Preparation, and Meshing17.11.2026 21:10:00 EET | Press release
Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced the availability of its 2027 1.0 Release. This latest release introduces new capabilities and enhancements across Spatial's 3D ACIS Modeler, CGM Modeler, 3D InterOp, Data Prep and CSM/CVM product lines. Designed to improve efficiency, flexibility and robustness across CAD modeling, interoperability, data preparation and simulation workflows, the release delivers enhanced geometry processing, expanded modeling capabilities, improved CAD translation and advances in mesh generation for a better workflow coverage. 3D ACIS Modeler Enhanced Blending (Filleting) The 3D ACIS Modeler introduces support for asymmetric fixed-width blends with a conic cross-section, providing users with finer control over smooth transitions between edges. This enhancement builds on the symmetric fixed-width blend with a conic cross-section capabilit
Global EV Alliance Survey: EV Drivers Identify Myths and Misconceptions as the Biggest Barrier to Adoption17.11.2026 20:00:00 EET | Press release
Myths and misconceptions about electric cars, from battery lifespan and fire risk to grid collapse, are the biggest barrier to EV adoption, according to respondents to the annual Global EV Driver Survey. The 2026 survey draws on responses from more than 29,500 EV drivers across 34 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117539716/en/ MYTHS. Battery lifespan (72%), fire risk (58%) and grid collapse (45%) top the list of EV myths reported by respondents to the 2026 Global EV Driver Survey, which gathered responses from more than 29,500 EV drivers across 34 countries. “The EV transition is not just an infrastructure or affordability challenge. It is also an information challenge. Outdated information and misconceptions continue to influence decisions long after the technology has moved on,” says Ellen Hiep, from the Steering Committee of the Global EV Alliance (GEVA). Myths the greatest barrier Asked to ide
KILL Trulioo’s Global Risk Platform Unlocks Device and Behavioral Intelligence Via Bureau Partnership17.11.2026 20:00:00 EET | Press release
Trulioo requests that their press release NewsItemId: 20261117163539 “Trulioo’s Global Risk Platform Unlocks Device and Behavioral Intelligence Via Bureau Partnership” be killed. The release was issued in error by Trulioo.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
